APT(SH:688617) Sou Hu Cai Jing·2025-04-10 12:55Company Overview - Shenzhen Huatai Medical Devices Co., Ltd. specializes in the research, production, and sales of cardiovascular interventional medical devices, with key products including electrophysiology, coronary access, peripheral vascular interventional, and non-vascular interventional medical devices [1] - The company's electrophysiological electrode catheters and radiofrequency ablation electrode catheters are the first domestically approved products, establishing a leading position in the domestic electrophysiology market [1] Financial Performance - For the third quarter of 2024, the company reported a revenue of 1.525 billion yuan, representing a year-on-year increase of 25.63% [1] - The net profit for the same period was 528 million yuan, showing a year-on-year growth of 30.97% [1] - The gross profit margin stood at 72.69% [1] Market Position - As of the latest report, Huatai Medical's stock closed at 433.0 yuan, with a PE ratio of 62.42, marking a new low in 125 days [1] - The total market capitalization of the company is 42.036 billion yuan [1] - In comparison to the industry average PE ratio of 46.15 and the median of 29.13, Huatai Medical ranks 100th in the industry [2] Institutional Holdings - A total of 479 institutions hold shares in Huatai Medical, with 478 being funds and 1 being a brokerage, collectively holding 30.0891 million shares valued at 11.203 billion yuan [1]